Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5356)	8/26/1998 11:43:00 AM
From: Mkilloran	Respond to of 7041

Linda...fyi #reply-5586842

To: Linda Kaplan who wrote (5356)	8/26/1998 1:25:00 PM
From: George Acton	Read Replies (1) \| Respond to of 7041

\| I think the issue will be whether any new drug, not as effective \| as Viagra, can penetrate Viagra's stronghold on the market. Not to mention Viagra's advantage in having received an enormous amount of favorable publicity in every medium from the Internet to smoke signals on remote Pacific islands. Obviously the only people who will try Vasomax will be treatment failures with Viagra. And Vasomax will be in competition with several alternatives. I hope you're short a ton of this stock, because you deserve some kind of tangible reward for your saintly patience in posting to this thread. --George Acton